Job titles of the future: Nature's drug designer
Tim Cernak uses AI and robotics to design drugs for animals and ecosystems, not just people.
Intelligence analysis by GPT-5.4 Mini
After years in Big Pharma, Tim Cernak is applying drug-design tools to conservation problems. His work, which he calls conservation chemistry, uses AI-driven protein modeling and lab robots to build treatments for frogs, turtles, birds, and even trees.
A scientist is using computer smarts and lab robots to make medicines for animals and even trees. It is like designing a key for a very specific lock, except the lock belongs to a frog, a turtle, or a tree instead of a person.
Analysis
From human medicine to conservation chemistry
Tim Cernak spent nearly two decades in Big Pharma, where he helped develop precision therapies for cancer, HIV, and diabetes at Merck. In 2018, he shifted toward a different problem: treating non-human patients. The article frames this as a move from human-centered medicine to what he calls “conservation chemistry.”
How AI changes the workflow
Cernak uses AI to make drug design faster and less trial-and-error. The piece highlights Google DeepMind’s AlphaFold, which lets him visualize a mutant protein in three dimensions on a screen instead of relying on older lab methods. From there, he can generate candidate molecules that might bind to that structure. Robotics then help him run experiments at scale, with the article saying he can push through as many as 1,500 reactions a day.
Who the patients are
His work spans unusual targets: a Gila monster with a parasite, bald eagles with avian flu, loggerhead sea turtles with contagious tumors, and hemlock trees threatened by invasive species. He is especially drawn to creatures that have influenced human medicine, such as the Gila monster, whose biology helped inspire drugs like Ozempic.
The promise and the warning
The article also stresses that conservation chemistry has a mixed history. It points to DDT’s damage to bald eagle populations and cow painkillers that killed millions of Indian vultures. Cernak argues that leaving chemists out of conservation wastes a powerful toolset, but the history makes clear that any new chemical intervention has to be used carefully.
Key points
- Tim Cernak left Big Pharma to apply drug-design methods to wildlife and conservation problems.
- He uses AI tools like AlphaFold to model proteins and generate candidate molecules more quickly.
- Robots in the lab help him test large numbers of reactions, speeding up the discovery process.
- His work spans animals and plants, including turtles, eagles, frogs, and hemlock trees.
- The article emphasizes that conservation chemistry has promise, but also a troubling history of environmental harm.
If this approach works well, conservation teams could get faster, more precise treatments for sick animals and damaged ecosystems. AI and robotics could also make it easier to test many ideas quickly instead of relying on slow, broad-spectrum chemicals.
The article’s history lesson shows the danger: chemical fixes for nature can have unintended, widespread harm. Even with better targeting, conservation chemistry could still repeat past mistakes if the risks are misunderstood or the treatments are too blunt.
